Therapy News and Research

RSS

AI-based MRI tools show promise in multiple sclerosis diagnosis

A groundbreaking study in NPJ Digital Medicine demonstrates the superior accuracy of AI-based imaging in diagnosing and monitoring multiple sclerosis.

23 Oct 2023

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).

22 Oct 2023

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%

The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.

22 Oct 2023

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

22 Oct 2023

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo after surgery.

22 Oct 2023

Nature videos boost adolescent mental health: Study shows reduced stress and improved mood

Brief nature video exposure improved stress, mood, and relaxation, highlighting the potential of nature-based interventions for adolescent mental health.

22 Oct 2023

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

SARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.

22 Oct 2023

Scientists uncover a group of immune cells that may drive severe asthma in older men

Scientists from La Jolla Institute for Immunology (LJI) and The University of Southampton, UK, have uncovered a group of immune cells that may drive severe asthma.

20 Oct 2023

Scientists develop gene therapy approach for rare paralyzing disease

The 50 families stretch from the Netherlands and the United Kingdom to the United States and China. Each family has a child who is paralyzed from a mutation in a single gene named Contactin-Associated Protein 1 (Cntnap1).

20 Oct 2023

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

Atovaquone "chemical vaccine" for malaria could be more feasible than thought

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.

20 Oct 2023

Adverse childhood experiences have long-term impact on mental and emotional health

Adverse childhood experiences (ACEs) are defined as a series of stressful or traumatic events including abuse, neglect or dysfunctions in the home (relatives with mental illness or in prison, witnessing domestic violence, etc.).

20 Oct 2023

Pupil size may predict response to TMS treatment for depression

New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation (TMS) treatment of major depressive disorder.

20 Oct 2023

New funding from Breast Cancer Now supports research on treatment-resistant ER-positive breast cancer

Researchers are investigating how the most common type of breast cancer resists hormone therapy, thanks to new funding from Breast Cancer Now.

20 Oct 2023

First-of-its kind hormone replacement therapy improves symptoms in patients with adrenal conditions

A first-of-its kind hormone replacement therapy that more closely replicates the natural circadian and ultradian rhythms of our hormones has shown to improve symptoms in patients with adrenal conditions.

19 Oct 2023

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

Dementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston from Oct. 24 to 27.

19 Oct 2023

Study tests recast therapy for bilingual children with developmental language disorder

Amanda Owen Van Horne sits on the floor while a child mixes up cake batter in a play kitchen.

19 Oct 2023

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy.

19 Oct 2023

Stanford Medicine researchers find new way to measure ocular aging

Using a technique they developed for studying eye fluid, Stanford Medicine researchers and their collaborators have found a way to measure ocular aging, opening avenues for treatment of numerous eye diseases.

19 Oct 2023

Collaborative team receives NCI grant to study how to improve immunotherapy for diffuse midline gliomas

Each year, approximately 200 to 300 children in the United States are diagnosed with diffuse midline gliomas (DMG), a tumor that begins in the brain or spinal cord.

19 Oct 2023

Therapy News and Research

AI-based MRI tools show promise in multiple sclerosis diagnosis

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

Nature videos boost adolescent mental health: Study shows reduced stress and improved mood

COVID-19 tied to elevated risk of benign prostatic hyperplasia complications

Scientists uncover a group of immune cells that may drive severe asthma in older men

Scientists develop gene therapy approach for rare paralyzing disease

Study reveals how tuberculosis bacteria form cords to resist antibiotics

Atovaquone "chemical vaccine" for malaria could be more feasible than thought

Adverse childhood experiences have long-term impact on mental and emotional health

Pupil size may predict response to TMS treatment for depression

New funding from Breast Cancer Now supports research on treatment-resistant ER-positive breast cancer

First-of-its kind hormone replacement therapy improves symptoms in patients with adrenal conditions

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

Study tests recast therapy for bilingual children with developmental language disorder

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

Stanford Medicine researchers find new way to measure ocular aging

Collaborative team receives NCI grant to study how to improve immunotherapy for diffuse midline gliomas

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News